FA
KRMD icon

Friess Associates’s KORU Medical Systems KRMD Stock Holding History

Friess Associates’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-208,307
Closed -$1.56M – 117
2020
Q1 		$1.56M Buy
+208,307
New +$1.4M 0.16% 85

Other funds holding KRMD

HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Friess Associates's KRMD Position: Q2 2020 in Review

Friess Associates sold out of KORU Medical Systems (KRMD) in Q2 2020, closing a stake of 208,307 shares — an estimated $1.56M sold.

Friess Associates first reported a position in KRMD in Q1 2020 and held it in 1 quarter. The position peaked at $1.56M in Q1 2020. 89 funds tracked by Wall St. Rank hold KRMD as of Q2 2020.

  • Friess Associates reported no remaining KORU Medical Systems position as of Q2 2020 after selling out during the quarter.
  • Friess Associates sold 208,307 KORU Medical Systems shares in Q2 2020, an estimated $1.56M.
  • Friess Associates first reported a position in KORU Medical Systems in Q1 2020 and held it in 1 quarter.
  • Friess Associates's KORU Medical Systems position peaked at $1.56M in Q1 2020.
  • 89 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2020.

Based on Friess Associates's 13F filing for Q2 2020, filed 14 Aug 2020.